Discover why Crispr Therapeutics AG is a strong buy with FDA-approved Casgevy, a promising pipeline, and major growth ...

It might be time to look a bit off the beaten path, at names that can stand up to any AI-stock-led correction.

The Vacaville City Council held a study session at Thursday evening’s Special City Council Meeting to receive an update from staff regarding economic development. Don Burrus, Director of ...

Five years on from being the first person in the world to receive intravenous CRISPR treatment, Westmeath woman describes the clinical trial she participated in as ‘life-changing’ ...

Five years ago this month, in November 2020, medical history was made at Richmond Pharmacology when a patient received the ...

Integrates ToolGen's best-in-class CRISPR-Cas9 platform with GenEditBio's industry-leading lipid nanoparticle (LNP) delivery ...

When UC Berkeley biochemist Jennifer Doudna first began studying how bacteria fight virus infections, she had no idea it ...

Five years ago this month, in November 2020, medical history was made at London-based contract research organisation, Richmond Pharmacology, when a patient received the first CRISPR therapy delivered ...

Growing up in Tanzania, Prisca witnessed malaria as a daily reality with children missing school and families spending their limited savings on treatment. Witnessing how a preventable disease could ...

As reported in the Wall Street Journal, Armstrong has now officially entered the designer-baby business by funding heritable ...

A session at the AHA Scientific Sessions 2025 focused on the latest groundbreaking trails in cardiometabolic therapies.

Vertex Pharmaceuticals Incorporated VRTX stock has risen 9.2% in the past three months. However, the stock has significantly ...